Kyowa Hakko Kirin signs AI drug R&D deal with InveniAIArtificial intelligence and machine learning company InveniAI has joined with Kyowa Hakko Kirin to harness the power of Share XKyowa Hakko Kirin signs AI drug R&D deal with InveniAIhttps://pharmaphorum.com/news/kyowa-hakko-kirin-signs-ai-drug-rd-deal-with-inveniai/
Kyowa Kirin to expand UK headquarters despite BrexitOther Japanese firms could scale back UK investment. Share XKyowa Kirin to expand UK headquarters despite Brexithttps://pharmaphorum.com/news/kyowa-kirin-expand-uk-headquarters/